Feature Details Company Milestones and 2025 Catalysts Across Gene Therapy and Ophthalmic ProgramsNEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- PRISM MarketView today published a Q&A feature with Dr.

Presbyopia correction and other eye care accessibility measures can radically enhance independence, confidence, and productivity.

Piper Sandler analyst Biren Amin assumed coverage of Lenz Therapeutics (LENZ) with an Overweight rating with a price target of $51, up from ...

This story has a lot of personal sentiment and comes from the last words spoken by my brother at the end of 2018, the day he ...

The professor was honoured at the 40th Asia-Pacific Academy of Ophthalmology (APAO) Congress held in conjunction with the ...

A new drug application has been submitted for Brimochol™ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.

BRIMOCHOL PF’s combination of brimonidine and carbachol produces a “pinhole effect,” which is intended to improve depth of ...

With a range of treatments available for presbyopia, the challenge for clinicians is to guide patients toward the most ...

Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an ...

Presbyopia is a common eye condition which makes it more challenging to see nearby objects ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical ...

Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, ...